Related Experiment Videos
An automated method to prepare cell suspensions from human biopsy samples for immunophenotyping by flow cytometry
M J Warzynski1, A E Podgurski, D M Boldt
1Baystate Medical Center, Springfield, Massachusetts 01199.
American Journal of Clinical Pathology
|January 1, 1990
Summary
An automated method rapidly prepares single-cell suspensions from human biopsies in seconds, significantly faster than manual techniques. This efficient process maintains cell viability for crucial flow cytometry immunophenotyping and other analyses.
Area of Science:
- Biomedical Engineering
- Clinical Laboratory Science
- Hematology
Background:
- Manual preparation of single-cell suspensions from human biopsies is time-consuming.
- Current methods may pose risks of personnel exposure to infectious materials and external contamination.
Purpose of the Study:
- To compare the efficiency and efficacy of an automated versus a manual method for preparing single-cell suspensions from human biopsy samples.
- To evaluate the suitability of the automated method for flow cytometry immunophenotyping and other related assays.
Main Methods:
- An automated instrument utilizing a reciprocating paddle system for fluid shear was compared to a manual method.
- Preparation time, cell viability, and immunophenotyping results were assessed using various human biopsy samples, including B- and T-lymphocytic malignancies.
Main Results:
- The automated method consistently prepared single-cell suspensions significantly faster (15-30 seconds) than the manual method (10-15 minutes).
- Cells isolated via the automated method were viable and suitable for flow cytometry immunophenotyping, yielding comparable results to the manual method.
- The automated technique has been successfully used for over 50 clinical samples.
Conclusions:
- The automated method offers a rapid, efficient, and safe alternative for preparing single-cell suspensions in clinical flow cytometry labs.
- This technology streamlines immunophenotyping and shows potential for other assays involving hematopoietic malignancies.